Default: Drug Design, Development and Therapy

ISSN:

Journal Home

Journal Guideline

Drug Design, Development and Therapy Q1 Unclaimed

Dove Medical Press Ltd. New Zealand
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drug Design, Development and Therapy is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 94. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 2079 €. The scope of the journal is focused on drug design, drug safety, drug development, pharmaecuticals. It has an SJR impact factor of 0,999 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,999.

Drug Design, Development and Therapy focuses its scope in these topics and keywords: apoptosis, signaling, induced, nuclear, breast, factor, treatment, ovarian, brain, pathway, ...

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

2079 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Drug Design, Development and Therapy

0,999

SJR Impact factor

94

H Index

271

Total Docs (Last Year)

1141

Total Docs (3 years)

13688

Total Refs

5855

Total Cites (3 years)

1136

Citable Docs (3 years)

4.89

Cites/Doc (2 years)

50.51

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


apoptosis, signaling, induced, nuclear, breast, factor, treatment, ovarian, brain, pathway, autoimmune, autophagy, cancersynergistic, carcinoma, cardiac, cell, augments, attenuates, asubasubnbspnbspreceptor, adenovirus, agonist, algorithms, characterization, andnbspin, antiamyloidogenic, antitumor, application, arborescens, armed, asthmapivet, drug design, drug safety, drug development, pharmaecuticals

FAQS